comparemela.com

Latest Breaking News On - Paediatric neurology - Page 5 : comparemela.com

Stoke Therapeutics Presents Data From Multiple Studies of Children and Adolescents With Dravet Syndr

– Data from clinical studies of STK-001 demonstrated clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for disease modification –– Analysis of 72 patients treated in STK-001 clinical trials suggests that higher.

Honouring Healthcare Heroes - Sitaram Jaipuria Foundation Celebrates Medical & Healthcare Excellence Awards - 2nd Edition

New Delhi [India], November 29: At the second edition of the Sitaram Jaipuria Foundation s prestigious Medical and Healthcare Excellence Awards, Rs. 90 lakhs were awarded to medical professionals for their invaluable contribution towards the health and well-being of our society.

Stoke Therapeutics to Present Data from the Company s Dravet Syndrome Clinical Program at the American Epilepsy Society 2023 Annual Meeting -November 21, 2023 at 08:05 am EST

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.